During the past decade, Heart Center Research conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 9 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 4 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Heart Center Research" #1 sponsor was "Abbott Medical Devices" with 6 trials, followed by "Boston Scientific Corporation" with 3 trials sponsored, "Duke University" with 2 trials sponsored, "Gilead Sciences" with 2 trials sponsored and "Medtronic Cardiac Rhythm and Heart Failure" with 2 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Heart Center Research" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 3 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 2 trials as a collaborator, "Bracco Diagnostics, Inc" with 1 trials as a collaborator, "California Institute for Regenerative Medicine (CIRM)" with 1 trials as a collaborator and "Mayo Clinic" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Heart Center Research" are "Heart Failure" (7 trials), "Coronary Artery Disease" (6 trials), "Atrial Fibrillation" (4 trials), "Myocardial Infarction" (3 trials) and "Acute Coronary Syndrome" (2 trials). Many other conditions were trialed in "Heart Center Research" in a lesser frequency.

Most popular intervention types in "Heart Center Research" are "Drug" (19 trials), "Device" (15 trials), "Other" (5 trials), "Biological" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Darusentan" (2 trials), "Guanfacine" (2 trials), "ATI-5923" (1 trials) and "Accent MRI system (lead safety)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Heart Center Research" are 38 trials for "All" genders.

Currently, there are NaN active trials in "Heart Center Research". undefined are not yet recruiting, 4 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Heart Center Research, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Heart Center Research, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 14 trials that are defined as “Not Applicable".